Skip to main content
Figure 2 | Arthritis Research & Therapy

Figure 2

From: Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs

Figure 2

Antibody levels for serotype 23F at vaccination, at 4to 6 weeks after vaccination, and at 1.5-year follow-up in patients with rheumatoid arthritis (RA) and spondyloarthropathy (SpA) treated with different antiinflammatory drugs. Antibody levels ≥1 mg/L were considered putative protective (short dashed line).

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us